Secretive Project Prometheus takes VC Bob Nelsen beyond just health care - statnews.com

Venture capitalist Bob Nelsen is involved in a secretive initiative called Project Prometheus, expanding his focus beyond health care into broader scientific and technological domains.

1/14/2026

Vizgen Raises $48M With Support From ARCH, M Ventures, and Northpond - citybiz

Vizgen has successfully raised $48 million in funding, backed by investors including ARCH Venture Partners, M Ventures, and Northpond Ventures, to advance its spatial genomics technology.

1/8/2026

An Arch-backed biotech raises $53M to fight neurodegeneration - biopharmadive.com

An Arch Venture Partners-backed biotech company has raised $53 million in funding aimed at developing treatments for neurodegenerative diseases.

12/4/2025

SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer - PR Newswire

SciNeuro Pharmaceuticals announced a $53 million financing round to advance its pipeline of therapies targeting neurodegenerative diseases, alongside the appointment of a new Chief Financial Officer.

12/4/2025

Arch Venture Partners, L.P. Stock Portfolio - Intellectia AI

This page presents the stock portfolio of Arch Venture Partners, L.P., a venture capital firm, as tracked and analyzed by Intellectia AI.

11/18/2025

Even Bigger Venture Bucks For Obesity Therapies As Metsera Sells For Up To $10B - Crunchbase News

Metsera, an obesity therapy startup, is being acquired for up to $10 billion, signaling growing venture capital interest in the weight-loss treatment space amid rising demand for GLP-1 drugs.

11/12/2025

Ollin Biosciences Launches with Mission to Accelerate Best-in-class Therapies in Ophthalmology - BioSpace

Ollin Biosciences has officially launched with a focus on developing best-in-class therapies in ophthalmology, aiming to advance innovative treatments for eye diseases.

9/18/2025

A family affair: Langers team up to invest in intersection of technology, biology - FirstWord Pharma

The Langer family is joining forces to invest in ventures at the crossroads of technology and biology, signaling a collaborative approach to funding innovation in the life sciences sector.

9/18/2025

Moderna co-founder collects $77.5m for T.Rx Capital - venturecapitaljournal.com

A co-founder of Moderna has raised $77.5 million for a new venture called T.Rx Capital, signaling continued investment activity in the biotech and life sciences sector.

9/18/2025

9 Chicagoland firms named among Time's top venture capital firms of 2025 - The Business Journals

Nine venture capital firms from the Chicagoland area have been recognized by Time magazine as among the top VC firms of 2025, highlighting the region's growing influence in the investment landscape.

8/26/2025

Biotech VC raises $200M to focus on Japan’s ‘untapped source’ of innovation - Fierce Biotech

A biotech venture capital firm has raised $200 million to invest in Japan's biotechnology sector, viewing the country as an untapped source of scientific innovation with significant global potential.

7/2/2025

AN Venture Partners Announces Final Close of $200M Fund I - Business Wire

AN Venture Partners has announced the final close of its debut fund at $200 million, marking a significant milestone for the venture capital firm as it looks to invest in early-stage startups.

7/2/2025

Arch's Keith Crandell talks Chicago, biotech - Axios

Arch Venture Partners' Keith Crandell discusses the growth of Chicago's biotech ecosystem and the firm's investment strategy in life sciences and emerging technologies.

6/20/2025